Recruiting

Creatine Monohydrate

Sponsor:

University of North Carolina, Chapel Hill

Code:

NCT07795853

Conditions

Post-partum

Women

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Not accepted

Interventions

Creatine Monohdyrate

Study Details

Brief summary:

The purpose of this randomized, double-blind, parallel-group trial is to compare the effects of two doses of creatine monohydrate (5 g/day versus 10 g/day) administered for four weeks in postpartum women. The study will evaluate exercise performance, post-exercise recovery, cognitive function, and brain creatine concentrations in a sub-sample.

Conditions

Post-partum

Women

Study ID

NCT07795853

Start date

Sep 28, 2026

Status verified date

Aug, 2026

Completion date

Jul 10, 2027

Anticipated

Primary completion date

Jul 10, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 6 weeks -12 months postpartum
  • Body mass index of 18.5-34.9 kg/m2
  • Cleared to resume physical activity

Exclusion Criteria:

  • Experienced a musculoskeletal injury, excluding a Cesarean delivery,within the past three months that inhibits participation in the study.
  • Has chronic kidney disease, liver disease, chronic obstructive pulmonary disease, or cancer
  • Currently using medications that may directly impact the primary outcomes including: diuretics and corticosteroids).
  • Has uncontrolled hypertension or diabetes, or has recently started medication, without a stable dose for 3 consecutive months.
  • Currently using creatine monohydrate or other performance-enhancing supplements
  • Has a self-identified or clinically diagnosed eating disorder
  • Taking or having supplemented with creatine monohydrate in the last 28-days
  • Medical contradictions for physical exercise
  • Has participated in another clinical trial within 4-weeks prior to enrollment that in the opinion of the PI would influence the results.
  • Has severely impaired hearing or speech or inability to speak English.
  • Unwilling or unable to comply with the study protocol, including abstaining from caffeine, tobacco, alcohol, and physical activity before testing days.
  • Is currently pregnant.
  • Has a known allergy to the transducer gel used for the ultrasound
  • Has a known allergy to creatine monohydrate

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Low-Dose Creatine Monohydrate

Participants consume 5 grams per day of creatine monohydrate for 28 consecutive days.

experimental: High-dose Creatine Monohydrate

Participants consume 10 grams per day of creatine monohydrate for 28 consecutive days.

Interventions

Creatine Monohdyrate

Creatine monohydrate taken daily mixed with 6-8 oz of water.

Primary outcome measure

  • Repeated Sprint Ability Peak Power [ Time Frame: Change from baseline to 4 weeks post-supplementation. ]
  • Fatigue Index [ Time Frame: Change from baseline to 4 weeks post-supplementation. ]

Central Contacts and Locations

Central contacts

Locations

Applied Physiology Laboratory

Recruiting

Chapel Hill, North Carolina, United States, 27599

Contacts

Principal Investigator:

Abbie Smith-Ryan, PhD

More Information

Sponsor

University of North Carolina, Chapel Hill

Last update posted

Nov 18, 2026

Last verified

Aug, 2026

Keywords

  • exercise
  • creatine monohydrate
  • post-partum
  • women's health
  • recovery
  • cognition

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by University of North Carolina, Chapel Hill on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.